Evidence map›Paper›PMID 35617671›Full record

ArticleJMIR formative research2022

Mandatory Vaccination Against COVID-19: Twitter Poll Analysis on Public Health Opinion.

Valentin Ritschl, Fabian Eibensteiner, Erika Mosor, Maisa Omara, Lisa Sperl, Faisal A Nawaz, Chandragiri Siva Sai, Merisa Cenanovic, Hari Prasad Devkota, Mojca Hribersek and 9 more

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 5 countries.

Valentin Ritschl *Section for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-8763-8215
Fabian Eibensteiner *Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-5012-3082
Erika MosorSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-4293-0647
Maisa OmaraSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-8834-2333
Lisa SperlSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0089-8696
Faisal A NawazCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.ORCID https://orcid.org/0000-0002-0701-7628
Chandragiri Siva SaiAmity Institute of Pharmacy, Amity University, Uttar Pradesh, India.ORCID https://orcid.org/0000-0002-3037-3014
Merisa CenanovicSarajevo, Bosnia and Herzegovina.ORCID https://orcid.org/0000-0003-0719-7240
Hari Prasad DevkotaGraduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-0509-1621
Mojca HribersekLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-8200-1968
Ronita DeIndian Council of Medical Research-National Institute of Cholera and Enteric Diseases, West Bengal, India.ORCID https://orcid.org/0000-0002-1469-6139
Elisabeth KlagerLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-0722-1255
Eva SchadenLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-7571-8680
Maria Kletecka-PulkerLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-4901-7930
Sabine Völkl-KernstockLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-1951-1893
Harald WillschkeLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-9093-7563
Christoph AufrichtDivision of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0487-4296
Atanas G AtanasovLudwig Boltzmann Institute for Digital Health and Patient Safety, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-2545-0967
Tanja StammSection for Outcomes Research, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-3073-7284
Austrian Institute for Health Technology Assessment GmbH · ATLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · ATUniversity of Vienna · ATIndian Council of Medical Research · INInstitute of Genetics and Animal Biotechnology of the Polish Academy of Sciences · PLKumamoto University · JPMedical University of Vienna · ATMohammed Bin Rashid University of Medicine and Health Sciences · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOn January 30, 2020, the World Health Organization Emergency Committee declared the rapid worldwide spread of COVID-19 a global health emergency. By December 2020, the safety and efficacy of the first COVID-19 vaccines had been demonstrated. However, international vaccination coverage rates have remained below expectations (in Europe at the time of manuscript submission). Controversial mandatory vaccination is currently being discussed and has already been introduced in some countries (Austria, Greece, and Italy). We used the Twitter survey system as a viable method to quickly and comprehensively gather international public health insights on mandatory vaccination against COVID-19.

objectiveThe purpose of this study was to better understand the public's perception of mandatory COVID-19 vaccination in real time using Twitter polls.

methodsTwo Twitter polls were developed (in the English language) to seek the public's opinion on the possibility of mandatory vaccination. The polls were pinned to the Digital Health and Patient Safety Platform's (based in Vienna, Austria) Twitter timeline for 1 week in mid-November 2021, 3 days after the official public announcement of mandatory COVID-19 vaccination in Austria. Twitter users were asked to participate and retweet the polls to reach the largest possible audience.

resultsOur Twitter polls revealed two extremes on the topic of mandatory vaccination against COVID-19. Almost half of the 2545 respondents (n=1246, 49%) favor mandatory vaccination, at least in certain areas. This attitude contrasts with the 45.7% (n=1162) who categorically reject mandatory vaccination. Over one-quarter (n=621, 26.3%) of participating Twitter users said they would never get vaccinated, as reflected by the current Western European and North American vaccination coverage rate. Concatenating interpretation of these two polls should be done cautiously as participating populations might substantially differ.

conclusionsMandatory vaccination against COVID-19 (in at least certain areas) is favored by less than 50%, whereas it is opposed by almost half of the surveyed Twitter users. Since (social) media strongly influences public perceptions and views, and social media discussions and surveys are specifically susceptible to the "echo chamber effect," the results should be interpreted as a momentary snapshot. Therefore, the results of this study need to be complemented by long-term surveys to maintain their validity.

Indexed as

coronavirusCOVID-19hesitancymandatorymandatory vaccinationopinionperceptionpollpublic healthquestionnaireSARS-CoV-2social mediasupportsurveyTwittervaccinationvaccination hesitancyvaccine

Identifiers

PMID35617671
PMCPMC9217155
OpenAlexW4225722677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.